MA Dong. Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer[J]. Journal of Evidence-Based Medicine, 2006, 6(5): 277-280. DOI: 10.3969/j.issn.1671-5144.2006.05.007
|
Citation:
|
MA Dong. Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer[J]. Journal of Evidence-Based Medicine, 2006, 6(5): 277-280. DOI: 10.3969/j.issn.1671-5144.2006.05.007
|
MA Dong. Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer[J]. Journal of Evidence-Based Medicine, 2006, 6(5): 277-280. DOI: 10.3969/j.issn.1671-5144.2006.05.007
|
Citation:
|
MA Dong. Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer[J]. Journal of Evidence-Based Medicine, 2006, 6(5): 277-280. DOI: 10.3969/j.issn.1671-5144.2006.05.007
|
DownLoad: